{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:46:00Z","timestamp":1786977960646,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>The lack of immunocompetent small animal models for hepatitis C virus (HCV) has greatly hindered the development of effective vaccines. Using rodent hepacivirus (RHV), a homolog of HCV that shares many characteristics of HCV infection, we report the development and application of an RHV outbred rat model for HCV vaccine development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Approach and Results<\/jats:title>\n                    <jats:p>\n                      Simian adenovirus (ChAdOx1) encoding a genetic immune enhancer (truncated shark class II invariant chain) fused to the nonstructural (NS) proteins NS3\u2010NS5B from RHV (ChAd\u2010NS) was used to vaccinate Sprague\u2010Dawley rats, resulting in high levels of cluster of differentiation 8\u2013positive (CD8\n                      <jats:sup>+<\/jats:sup>\n                      ) T\u2010cell responses. Following RHV challenge (using 10 or 100 times the minimum infectious dose), 42% of vaccinated rats cleared infection within 6\u20108 weeks, while all mock vaccinated controls became infected with high\u2010level viremia postchallenge. A single, 7\u2010fold higher dose of ChAd\u2010NS increased efficacy to 67%. Boosting with ChAd\u2010NS or with a plasmid encoding the same NS3\u2010NS5B antigens increased efficacy to 100% and 83%, respectively. A ChAdOx1 vector encoding structural antigens (ChAd\u2010S) was also constructed. ChAd\u2010S alone showed no efficacy. Strikingly, when combined with ChAd\u2010NS, ChAD\u2010S produced 83% efficacy. Protection was associated with a strong CD8\n                      <jats:sup>+<\/jats:sup>\n                      interferon gamma\u2013positive recall response against NS4. Next\u2010generation sequencing of a putative RHV escape mutant in a vaccinated rat identified mutations in both identified immunodominant CD8\n                      <jats:sup>+<\/jats:sup>\n                      T\u2010cell epitopes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A simian adenovirus vector vaccine strategy is effective at inducing complete protective immunity in the rat RHV model. The RHV Sprague\u2010Dawley rat challenge model enables comparative testing of vaccine platforms and antigens and identification of correlates of protection and thereby provides a small animal experimental framework to guide the development of an effective vaccine for HCV in humans.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.30894","type":"journal-article","created":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T06:43:56Z","timestamp":1565419436000},"page":"794-807","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":28,"title":["Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus"],"prefix":"10.1097","volume":"71","author":[{"given":"Erwan","family":"Atcheson","sequence":"first","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Li","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly M.","family":"Bliss","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Chinnakannan","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Heim","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Sharpe","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hutchings","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunity,The Research Institute at Nationwide Children\u2019s Hospital,Columbus,OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Jarvis","sequence":"additional","affiliation":[{"name":"University of Plymouth, Plymouth Science Park,Plymouth,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Simmonds","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,Oxford,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"hep30894-bib-0002-20250501","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/474S2a","article-title":"Introduction: a smouldering public\u2010health crisis","volume":"474","year":"2011","journal-title":"Nature"},{"key":"hep30894-bib-0003-20250501","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, progress, and challenges to hepatitis C vaccine development","volume":"156","year":"2019","journal-title":"Gastroenterology"},{"key":"hep30894-bib-0004-20250501","first-page":"49","article-title":"Animal models for hepatitis C","volume":"369","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"hep30894-bib-0005-20250501","first-page":"1933","article-title":"Detection of zoonotic pathogens and characterization of novel viruses carried by commensal Rattus norvegicus in New York City","volume":"5","year":"2014","journal-title":"MBio"},{"key":"hep30894-bib-0006-20250501","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.29494","article-title":"Viral persistence, liver disease, and host response in a hepatitis C\u2013like virus rat model","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep30894-bib-0007-20250501","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41467-019-09105-0","article-title":"Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection","volume":"10","year":"2019","journal-title":"Nat Commun"},{"issue":"Suppl. 2","key":"hep30894-bib-0008-20250501","first-page":"46","article-title":"Hepatitis C virus vaccines among people who inject drugs","volume":"57","year":"2013","journal-title":"Clin Infect Dis"},{"key":"hep30894-bib-0009-20250501","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2008.11.049","article-title":"Rare birds in North America: acute hepatitis C cohorts","volume":"136","year":"2009","journal-title":"Gastroenterology"},{"key":"hep30894-bib-0011-20250501","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/cr.2014.116","article-title":"Persistent hepatitis C virus infections and hepatopathological manifestations in immune\u2010competent humanized mice","volume":"24","year":"2014","journal-title":"Cell Res"},{"key":"hep30894-bib-0012-20250501","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/338266","article-title":"The hepatitis C virus (HCV)\u2013trimera mouse: a model for evaluation of agents against HCV","volume":"185","year":"2002","journal-title":"J Infect Dis"},{"key":"hep30894-bib-0013-20250501","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/172.1.25","article-title":"Hepatitis C virus viremia in SCID \u2192 BNX mouse chimera","volume":"172","year":"1995","journal-title":"J Infect Dis"},{"key":"hep30894-bib-0014-20250501","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by the hepatitis C virus","volume":"91","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep30894-bib-0015-20250501","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","year":"2011","journal-title":"Immunol Rev"},{"key":"hep30894-bib-0016-20250501","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/JVI.78.1.187-196.2004","article-title":"Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine\u2010induced peripheral T\u2010helper immune response","volume":"78","year":"2004","journal-title":"J Virol"},{"key":"hep30894-bib-0017-20250501","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T\u2010cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","year":"2006","journal-title":"Nat Med"},{"key":"hep30894-bib-0018-20250501","first-page":"1060","article-title":"Successful vaccination induces multifunctional memory T\u2010cell precursors associated with early control of hepatitis C virus","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"hep30894-bib-0019-20250501","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/hep.26747","article-title":"Hepatitis C virus clearance correlates with HLA\u2010DR expression on proliferating CD8+ T cells in immune\u2010primed chimpanzees","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep30894-bib-0020-20250501","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","year":"2010","journal-title":"Gastroenterology"},{"key":"hep30894-bib-0021-20250501","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep30894-bib-0022-20250501","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus\u2010neutralizing antibodies and viral clearance in a single\u2010source outbreak of hepatitis C","volume":"104","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep30894-bib-0023-20250501","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JVI.78.3.1575-1581.2004","article-title":"Cross\u2010genotype immunity to hepatitis C virus","volume":"78","year":"2004","journal-title":"J Virol"},{"key":"hep30894-bib-0024-20250501","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep30894-bib-0025-20250501","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1099\/vir.0.80401-0","article-title":"Genetic diversity and evolution of hepatitis C virus\u201415 years on","volume":"85","year":"2004","journal-title":"J Gen Virol"},{"key":"hep30894-bib-0026-20250501","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2017.10.079","article-title":"The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes","volume":"36","year":"2018","journal-title":"Vaccine"},{"key":"hep30894-bib-0027-20250501","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1126\/science.1217521","article-title":"Guiding limited use of chimpanzees in research","volume":"335","year":"2012","journal-title":"Science"},{"key":"hep30894-bib-0028-20250501","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/s41598-018-33375-1","article-title":"Development of a molecular adjuvant to enhance antigen\u2010specific CD8+ T cell responses","volume":"8","year":"2018","journal-title":"Sci Rep"},{"key":"hep30894-bib-0029-20250501","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","year":"2001","journal-title":"J Exp Med"},{"key":"hep30894-bib-0030-20250501","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0016-5085(99)70353-7","article-title":"Recurrence of hepatitis C virus after loss of virus\u2010specific CD4+ T\u2010cell response in acute hepatitis C","volume":"117","year":"1999","journal-title":"Gastroenterology"},{"key":"hep30894-bib-0031-20250501","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/j.gastro.2006.11.044","article-title":"Discordant role of CD4 T\u2010cell response relative to neutralizing antibody and CD8 T\u2010cell responses in acute hepatitis C","volume":"132","year":"2007","journal-title":"Gastroenterology"},{"key":"hep30894-bib-0032-20250501","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.4049\/jimmunol.174.8.4559","article-title":"Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus","volume":"174","year":"2005","journal-title":"J Immunol"},{"key":"hep30894-bib-0033-20250501","first-page":"115ra1","article-title":"Novel adenovirus\u2010based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","year":"2012","journal-title":"Sci Transl Med"},{"key":"hep30894-bib-0034-20250501","first-page":"261ra153","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV\u2010specific T cell memory","volume":"6","year":"2014","journal-title":"Sci Transl Med"},{"key":"hep30894-bib-0035-20250501","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/sj.gt.3302754","article-title":"Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming\u2010boosting with novel adenoviral vectors based on different serotypes","volume":"13","year":"2006","journal-title":"Gene Ther"},{"key":"hep30894-bib-0036-20250501","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/JVI.80.4.1688-1699.2006","article-title":"A novel adenovirus type 6 (Ad6)\u2010based hepatitis C virus vector that overcomes preexisting anti\u2010Ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques","volume":"80","year":"2006","journal-title":"J Virol"},{"key":"hep30894-bib-0037-20250501","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","year":"2003","journal-title":"Science"},{"key":"hep30894-bib-0038-20250501","first-page":"E3503","article-title":"Merck Ad5\/HIV induces broad innate immune activation that predicts CD8+ T\u2010cell responses but is attenuated by preexisting Ad5 immunity","volume":"109","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep30894-bib-0039-20250501","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"hep30894-bib-0040-20250501","first-page":"115ra2","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","year":"2012","journal-title":"Sci Transl Med"},{"key":"hep30894-bib-0041-20250501","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1073\/pnas.1621489114","article-title":"Systems analysis of protective immune responses to RTS, S malaria vaccination in humans","volume":"114","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep30894-bib-0042-20250501","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1128\/JVI.00740-12","article-title":"Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys","volume":"86","year":"2012","journal-title":"J Virol"},{"key":"hep30894-bib-0043-20250501","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","year":"2003","journal-title":"J Exp Med"},{"key":"hep30894-bib-0044-20250501","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hep.21573","article-title":"Vaccine\u2010induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD\u20101 and chronicity","volume":"45","year":"2007","journal-title":"Hepatology"},{"key":"hep30894-bib-0045-20250501","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.gastro.2010.05.077","article-title":"Meta\u2010analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"hep30894-bib-0046-20250501","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20041006","article-title":"CD8 epitope escape and reversion in acute HCV infection","volume":"200","year":"2004","journal-title":"J Exp Med"},{"key":"hep30894-bib-0047-20250501","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nri3905","article-title":"Sizing up the key determinants of the CD8+ T cell response","volume":"15","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"hep30894-bib-0048-20250501","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2018.00276","article-title":"Features of effective T cell\u2010inducing vaccines against chronic viral infections","volume":"9","year":"2018","journal-title":"Front Immunol"},{"key":"hep30894-bib-0049-20250501","article-title":"Adenoviral vaccine induction of CD8+ T cell memory inflation: impact of co\u2010infection and infection order","volume":"13","year":"2017","journal-title":"PLoS Pathog"},{"key":"hep30894-bib-0050-20250501","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.4049\/jimmunol.1502687","article-title":"Modification of antigen impacts on memory quality after adenovirus vaccination","volume":"196","year":"2016","journal-title":"J Immunol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.30894","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.30894","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.30894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:01:33Z","timestamp":1746115293000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.30894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.30894","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"2019-05-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}